MYB_XENLA
ID MYB_XENLA Reviewed; 624 AA.
AC Q08759;
DT 01-FEB-1995, integrated into UniProtKB/Swiss-Prot.
DT 01-FEB-1995, sequence version 1.
DT 03-AUG-2022, entry version 110.
DE RecName: Full=Transcriptional activator Myb;
GN Name=myb;
OS Xenopus laevis (African clawed frog).
OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Amphibia;
OC Batrachia; Anura; Pipoidea; Pipidae; Xenopodinae; Xenopus; Xenopus.
OX NCBI_TaxID=8355;
RN [1]
RP NUCLEOTIDE SEQUENCE [MRNA].
RX PubMed=7509053;
RA Amaravadi L., King M.W.;
RT "Characterization and expression of the Xenopus c-Myb homolog.";
RL Oncogene 9:971-974(1994).
CC -!- FUNCTION: Transcriptional activator; DNA-binding protein that
CC specifically recognize the sequence 5'-YAAC[GT]G-3'. Plays an important
CC role in the control of proliferation and differentiation of
CC hematopoietic progenitor cells.
CC -!- SUBCELLULAR LOCATION: Nucleus.
CC -!- DOMAIN: Comprised of 3 domains; an N-terminal DNA-binding domain, a
CC centrally located transcriptional activation domain and a C-terminal
CC domain involved in transcriptional repression.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; L22741; AAC38011.1; -; mRNA.
DR PIR; I51581; I51581.
DR RefSeq; NP_001081768.1; NM_001088299.2.
DR AlphaFoldDB; Q08759; -.
DR SMR; Q08759; -.
DR GeneID; 398039; -.
DR KEGG; xla:398039; -.
DR CTD; 398039; -.
DR Xenbase; XB-GENE-867566; myb.S.
DR OrthoDB; 219341at2759; -.
DR Proteomes; UP000186698; Chromosome 5S.
DR Bgee; 398039; Expressed in egg cell and 11 other tissues.
DR GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:InterPro.
DR CDD; cd00167; SANT; 3.
DR InterPro; IPR015395; C-myb_C.
DR InterPro; IPR009057; Homeobox-like_sf.
DR InterPro; IPR017930; Myb_dom.
DR InterPro; IPR001005; SANT/Myb.
DR InterPro; IPR012642; Tscrpt_reg_Wos2-domain.
DR Pfam; PF09316; Cmyb_C; 1.
DR Pfam; PF07988; LMSTEN; 1.
DR Pfam; PF00249; Myb_DNA-binding; 3.
DR SMART; SM00717; SANT; 3.
DR SUPFAM; SSF46689; SSF46689; 2.
DR PROSITE; PS51294; HTH_MYB; 3.
PE 2: Evidence at transcript level;
KW Activator; DNA-binding; Nucleus; Reference proteome; Repeat; Transcription;
KW Transcription regulation.
FT CHAIN 1..624
FT /note="Transcriptional activator Myb"
FT /id="PRO_0000197051"
FT DOMAIN 32..83
FT /note="HTH myb-type 1"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00625"
FT DOMAIN 84..139
FT /note="HTH myb-type 2"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00625"
FT DOMAIN 140..190
FT /note="HTH myb-type 3"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00625"
FT DNA_BIND 60..83
FT /note="H-T-H motif"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00625"
FT DNA_BIND 112..135
FT /note="H-T-H motif"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00625"
FT DNA_BIND 163..186
FT /note="H-T-H motif"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00625"
FT REGION 264..314
FT /note="Transcriptional activation domain"
FT /evidence="ECO:0000250"
FT REGION 315..449
FT /note="Negative regulatory domain"
FT /evidence="ECO:0000250"
FT REGION 319..352
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT COMPBIAS 319..351
FT /note="Polar residues"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ SEQUENCE 624 AA; 72112 MW; B8F51A2BBA72E70B CRC64;
MDRRPSQYSS EEEDDEIEMY EHDYDGLLSK GKRHLGKTRW TREEDEKLKK LVEQNGTEEW
KVIASFLPNR TDVQCQHRWQ KVLNPELIKG PWTKEEDQRV IELVHKYGPK RWSVIAKHLK
GRIGKQCRER WHNHLNPEVK KSSWTEEEDR TIYEAHKRLG NRWAEIAKLL PGRTDNAIKN
HWNSTMRRKE EQEGYLQNSS KTNQHTIVTN FPKSNHLMTF THTRASAEHS QASTSSFPYY
HIAEHQNASY PVALRVNIVN VPQLATAPVQ RHYNDEDPEK EKRIKELELL LMSTENEINQ
KQELLNHTAS YTTCHSTTIG GNPRLHGQST PDSCLGDPHH STPSPQVDHS CLPEESASPA
RYFGVNLLIQ MKNLAEYSET QLIDSFLNTS TQHENLEMEH QSLTSTPICA SQKNTITTSL
LRDHALRLQK ENHLLRTPAI KRSILNSTPR TPTPFKNALA AQEFKHGPLK LLHHTPLHLA
EDIQEVIKQE TDESGIVHDH CNTEEPLLKR IKQEVESPTH KVGNLYFSSY WEGESLNAQL
FRQQSTLDDT SNSILTSSLL MKPVSEKEDH IFKSFPVQSI KSYTSPLQHL SGTWDVMSCS
RMEDQKILAE QYCKYIKNFS TLVI